Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to new research published in the September issue of The Journal of Nuclear Medicine. This same-day imaging approach has the potential to save valuable time in guiding treatment decisions and reduce unnecessary exposure to ineffective therapies.

Sep. 15, 2025 —ScanLabMR has introduced its Signal-to-Noise Ratio (SNR) calculator. This feature gives MRI technologists, radiologists and educators a smarter, more reliable way to understand and optimize image quality.

Sept. 15, 2025 — Mevion Medical Systems  announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy. 

Sept. 17, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that office-based imaging studies were more likely to be repeated within 90 days when the initial study was interpreted by a non-physician practitioner (nurse practitioner or physician assistant, NPP) than when interpreted by a radiologist. The study, published in the Journal of the American College of Radiology (JACR), was based on 1.3 million Medicare imaging claims between 2013 and 2022.

Sept. 16, 2025 –Proscia, a pathology AI company, recently announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges: managing surging data volumes and standardizing siloed data. It has integrated its Concentriq platform for pathology from drug discovery to diagnostics with AWS HealthImaging to provide laboratories and life sciences organizations with a cloud-native foundation, accelerating routine workflows and fueling AI-driven precision medicine initiatives.

Sept. 16, 2025 - ITM Isotope Technologies Munich SE (ITM) plans to unveil dosimetry data from its recent Phase 3 COMPETE trial in an oral presentation at the European Association of Nuclear Medicine (EANM) congress in October in Barcelona, Spain. The company will also host a satellite symposium on targeted theranostics for the treatment of neuroendocrine tumors (NETs) and “Meet the Expert” sessions at its conference booth. 

Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ultrasound portfolio. Designed to deliver detailed imaging and simplify workflow with artificial intelligence (AI) and automation tools, the new Voluson Performance 18 and 16 offers clinicians modern, innovative technology to assist with efficient care across a wide range of applications.

Sept. 15, 2025 — Cook Medical and Siemens Healthineers have announced a strategic commercial partnership aimed at setting a new standard for interventional medicine. The collaboration combines the power of Siemens Healthineers real-time magnetic resonance imaging with Cook Medical's deep interventional procedure expertise, along with new medical devices developed by Cook specifically for the MRI environment.

Sept. 10, 2025  — According to ARRS’ American Journal of Roentgenology (AJR), general-purpose large language models (LLMs) such as GPT-4 can detect and classify critical findings in radiology reports with high precision and recall when guided by carefully designed prompt strategies, highlighting their potential to support timely communication in clinical workflows.

Sept. 11, 2025 — A new PET tracer can provide insights into how spinal cord injuries affect not only the spinal cord, but also the brain, according to new research published in The Journal of Nuclear Medicine. By identifying synapse loss, the PET approach provides molecularly unique and complementary information to other structural imaging methods, offering a promising objective metric to evaluate novel therapeutics for spinal cord injuries.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now